ArticleTherapeutics and clinical risk management2007

A review of anti-IgE monoclonal antibody (omalizumab) as add on therapy for severe allergic (IgE-mediated) asthma.

Gennaro D'Amato et al.PubMed ↗Full text ↗

No numbers read from the abstract.